
    
      This study is a randomized, placebo-controlled trial in which subjects assigned to the
      modified fasting cohort will undergo consecutive weekly cycles of modified fasting for two
      consecutive days.

      The primary objective is to assess the effects of repeated periods of modified fasting on
      body weight.

      The secondary objectives include assessment of the effects of modified fasting on percent
      body fat, waist circumference and fasting levels of hs-CRP (hs-C-reactive protein), IL-6
      (Interleukin-6), IL-8 (interleukin-8), IL-12 (interleukin-12), TNF-a (tumor necrosis
      factor-alpha), IGF-1 (insulin-like growth factor 1), IGFBP-1 (insulin-like growth
      factor-binding protein 1) , Total Cholesterol, LDL cholesterol, HDL cholesterol, Glucose,
      Triglyceride, Insulin, Vitamin-D, 25-Hydroxy,

      Participants will undergo assessments of blood tests, vital signs, BMI, body weight, waist
      circumference and percent body fat.
    
  